Diuretics are among the most commonly prescribed drugs and, although effective, they are
often used to treat patients at substantial risk for complications, making it especially …

The incidence and prevalence of heart failure (HF) and chronic kidney disease (CKD) are
increasing, and as such a better understanding of the interface between both conditions is …

The management of heart failure has changed significantly over the last 30 years, leading to
improvements in the quality of life and outcomes, at least for patients with a substantially …

Diuretics have an essential role in the management of heart failure (HF). However, each
drug has its own benefit and side effect. Side effects include fluid, electrolyte abnormalities …

Background Approximately half of people with heart failure have chronic kidney disease
(CKD). Pharmacological interventions for heart failure in people with CKD have the potential …

Although torsemide's oral bioavailability and half-life theoretically render it a more efficient
diuretic than furosemide, the clinical outcomes of torsemide compared with furosemide …

Aims Loop diuretics have become a mainstay of chronic heart failure management.
Furosemide and torsemide are the two most common loop diuretics; nevertheless, there is …

Heart failure remains a huge societal concern despite medical advancement, with an annual
direct cost of over $30 billion. While guideline-directed medical therapy (GDMT) is proven to …

Background Torasemide is a potent loop diuretic with potential to treat congestive heart
failure (CHF) in dogs. Objective Evaluate the efficacy and safety of torasemide compared to …

Background Heart rate and systolic blood pressure (SBP) are prognostic markers in heart
failure (HF) with reduced ejection fraction (HFrEF). Their combination in rate pressure …